找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Kidney Disease in the Cardiac Catheterization Laboratory; A Practical Approach Janani Rangaswami,Edgar V. Lerma,Peter A. McCullou Book 2020

[复制链接]
楼主: centipede
发表于 2025-3-23 10:30:22 | 显示全部楼层
发表于 2025-3-23 16:35:03 | 显示全部楼层
发表于 2025-3-23 20:25:10 | 显示全部楼层
发表于 2025-3-24 00:25:38 | 显示全部楼层
Peripheral Arterial Disease in Chronic Kidney Disease: Disease Burden, Outcomes, and Interventional patients with chronic kidney disease (CKD). PAD is particularly common in those with severe CKD, and early detection and effective treatment of PAD is indicated in those with CKD and concomitant PAD. Measurement of the ankle-brachial index is a simple, reliable, and noninvasive test to diagnose PAD
发表于 2025-3-24 03:03:22 | 显示全部楼层
Cardiovascular Impact of Atherosclerotic Renovascular Diseaseich activates the renin-angiotensin-aldosterone system and increases a variety of inflammatory and pro-fibrotic cytokines. This results in the development of hypertension and a decline in renal function. Unfortunately the finding of renal artery stenosis does not always imply the presence of renal i
发表于 2025-3-24 08:23:50 | 显示全部楼层
Therapeutic Considerations with Revascularization in Chronic Kidney Disease: Radial Versus Femoral Atable settings. Recent evidence suggests potential nephroprotective benefits of the radial approach over the femoral route toward both short- and long-term kidney injury preventions. Acute kidney injury (AKI) after cardiac catheterization remains a major issue in hospitalized patients and is associa
发表于 2025-3-24 10:59:22 | 显示全部楼层
Antiplatelet Agent Choice and Platelet Function Testing in CKD of the platelet COX-1 enzyme by aspirin and the P2Y.-ADP interaction by P2Y. receptor inhibitors is a major pharmacologic strategy to prevent acute as well as long-term thrombotic event occurrences following PCI. Clopidogrel, the most widely used P2Y. receptor inhibitor, is associated with wide res
发表于 2025-3-24 16:35:22 | 显示全部楼层
Choice of Stents and Clinical Outcomes in Patients with Chronic Kidney Diseases (ST) following percutaneous coronary intervention (PCI). However, patients with chronic kidney disease (CKD) are characterized by unique risk factors that ought to be considered when selecting a coronary stent. In addition to the systemic risk factors in patients with CKD, atherosclerotic lesions
发表于 2025-3-24 22:20:37 | 显示全部楼层
Revascularization Strategies in Chronic Kidney Disease: Percutaneous Coronary Interventions Versus Cis associated with the development and progression of atherosclerotic cardiovascular disease. In addition to traditional cardiovascular risk factors such as hypertension, smoking, diabetes mellitus, and hyperlipidemia, patients with CKD also carry nontraditional risk factors such as increased vascul
发表于 2025-3-25 02:54:32 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-6 06:18
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表